Skip Navigation

Antioxidant actions contribute to the antihypertrophic effects of atrial natriuretic peptide in neonatal rat cardiomyocytes

  1. Adrienne Laskowskia,b,
  2. Owen L. Woodmanb,
  3. Anh H. Caoa,
  4. Grant R. Drummondc,
  5. Tanneale Marshalla,
  6. David M. Kayea and
  7. Rebecca H. Ritchiea,b,*
  1. aWynn Department of Metabolic Cardiology, Baker Heart Research Institute, Melbourne 8008, Australia
  2. bDepartment of Pharmacology, University of Melbourne 3010, Australia
  3. cDepartment of Pharmacology, Monash University, Clayton 3800, Victoria, Australia
  1. *Corresponding author. Wynn Department of Metabolic Cardiology, Baker Heart Research Institute, PO Box 6492, St Kilda Rd Central, Melbourne, VIC, 8008, Australia. Tel.: +61 3 8532 1392; fax: +61 3 8532 1100. Email address: rebecca.ritchie{at}baker.edu.au
  • Received December 20, 2005.
  • Revision received June 30, 2006.
  • Accepted July 3, 2006.

Abstract

Objective: Reactive oxygen species (ROS) such as superoxide have been linked to the hypertrophic response of the heart to stimuli including angiotensin II (AngII), mechanical stretch, and pressure overload. We have previously demonstrated that cGMP and protein kinase G mediate the antihypertrophic actions of the natriuretic peptides in rat cardiomyocytes and isolated whole hearts. The impact of natriuretic peptides on cardiac ROS generation, however, has not been investigated. We tested the hypothesis that reduced superoxide accumulation contributes to the antihypertrophic action of atrial natriuretic peptide (ANP).

Methods: Neonatal rat cardiomyocytes were cultured in serum-free medium with and without AngII (1μmol/L) or endothelin-1 (ET1, 60nmol/L) in the presence and absence of ANP (1μmol/L) or tempol (100μmol/L). Hypertrophic responses, cardiomyocyte superoxide generation, and cardiomyocyte expression of NADPH oxidase were determined.

Results: AngII induced increases in cardiomyocyte size (to 176±9% n=8 p<0.001, at 48h), β-myosin heavy chain expression (to 4.0±1.6-fold n=6 p<0.05, at 48h), c-fos expression (to 1.9±0.5-fold n=7 p<0.01, at 6h), superoxide generation (to 181±21% n=8 p<0.005, at 24h), and expression of the gp91phox subunit of NADPH oxidase (to 2.4±0.5-fold n=7 p<0.05, at 48h). These effects were all significantly inhibited by ANP: cardiomyocyte size, β-myosin heavy chain expression, c-fos expression, superoxide generation and gp91phox expression were reduced to 107±5% (n=5 p<0.05), 1.2±0.2-fold (n=6 p<0.05), 0.9±0.2-fold (n=7 p<0.05), 141±21% (n=8 p<0.05), and to 1.0±0.5-fold (n=7 p<0.05), respectively. These effects were mimicked by tempol. ANP and tempol also significantly inhibited ET1-induced increases in cardiomyocyte size and superoxide generation, but had no effect on markers of hypertrophy when studied alone.

Conclusion: This data indicates that the antihypertrophic actions of ANP are accompanied by reduced levels of superoxide, suggesting an antioxidant action contributes to the antihypertrophic actions of ANP.

Keywords

Key words

    « Previous | Next Article »Table of Contents

    This Article

    1. Cardiovasc Res (2006) 72 (1): 112-123. doi: 10.1016/j.cardiores.2006.07.006
    1. » AbstractFree
    2. Full Text (HTML)Free
    3. Full Text (PDF)Free

    Classifications

    Responses

    1. Submit a response
    2. No responses published

    Current Issue

    1. April 1, 2010, 86 (1)
    1. Current Issue
    1. Alert me to new issues

    Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.